Covered recipient · General Payments record
TIA LONDIA GUILLEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$953.71
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $953.71 | 39 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $208.06 | 5 |
| RECORDATI_RARE_DISEASES_INC. | $126.37 | 1 |
| ABBVIE INC. | $57.77 | 2 |
| Janssen Biotech, Inc. | $53.39 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.25 | 3 |
| Incyte Corporation | $45.54 | 2 |
| Genentech USA, Inc. | $43.56 | 3 |
| SOBI, INC | $39.87 | 2 |
| JAZZ PHARMACEUTICALS INC. | $37.87 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $37.08 | 2 |
| BeiGene USA, Inc. | $35.79 | 2 |
| Adaptive Biotechnologies Corporation | $22.97 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.81 | 1 |
| Apellis Pharmaceuticals, Inc. | $22.13 | 1 |
| Regeneron Healthcare Solutions, Inc. | $20.68 | 1 |
| Genmab U.S., Inc. | $18.95 | 1 |
| Blueprint Medicines Corporation | $16.76 | 1 |
| AVEO Pharmaceuticals, Inc. | $16.64 | 1 |
| Merck Sharp & Dohme Corporation | $16.56 | 1 |
| Alnylam Pharmaceuticals Inc. | $16.46 | 1 |
| SERVIER PHARMACEUTICALS LLC | $16.04 | 1 |
| GENZYME CORPORATION | $14.72 | 1 |
| Stemline Therapeutics Inc. | $13.44 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $953.71 | 39 |
Payment records · PY2024 (39)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.